Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusion.

Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusion. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusion. Abstract Text:

Biswadeep Das,Chayna Sarkar,P Ravi Shankar,Biswadeep Das,Chayna Sarkar,P Ravi Shankar,

BACKGROUND: Endothelial ET(B) receptor activation by exogenously administered sarafotoxin 6c(a snake venom peptide with a sequence homology to ET-1 prior to ischemia activates release of nitric oxide(NO) and previous studies have shown that NO facilitates mitochondrial K(ATP) activation in cardiac cells and cardioprotection. OBJECTIVES AND METHODS: The aim of this investigation was to test whether the administration of sarafotoxin 6c(a selective ET(B) receptor agonist) has cardioprotective and antiarrhythmic effects against ischemia and reperfusion injury in a well-standardized model of reperfusion arrhythmias in anesthetized adult male rabbits (n = 53) subjected to 30 min occlusion of the left coronary artery followed by 120 min of reperfusion. RESULTS: Pretreatment with sarafotoxin 6c (0.24 nmol/kg, i.v.) prior to the period of coronary occlusion offers significant infarct size reduction (19.1 +/- 2.0% versus 39.7 +/- 3.7% in the saline control group; P < 0.01) and antiarrhythmic effects. Sarafotoxin 6c treatment significantly attenuated the incidence of life-threatening arrhythmias like sustained VT (13 versus 100% in the saline control group; P < 0.005) and other arrhythmias (25 versus 100% in the saline control group; P < 0.005), and increased the number of surviving animals without arrhythmias. Pretreatment with 5-HD but not HMR 1883 abolished the beneficial effects of sarafotoxin 6c on reperfusion induced arrhythmias and cardioprotection suggesting that benefits have been achieved via the selective activation of cardiomyocyte mitochondrial K(ATP) channels. Sarafotoxin 6c evoked NO release and selective activation of mitoK(ATP) channels in cardiomyocytes contributes to cardioprotection and antiarrhythmic activity during ischemia-reperfusion in the anesthetized rabbit. CONCLUSIONS: We conclude that the selective activation of ET(B) receptors by sarafotoxin 6c prior to coronary occlusion contributes to cardioprotective and antiarrhythmic properties.

Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusion. Publishing Authors By Initials

B Das,C Sarkar,PR Shankar,B Das,C Sarkar,PR Shankar,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusion. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cardiovascular drugs and therapy / sponsored by th

VOLUME: 21

Page Numbers: 243-51

Journal Abbreviation:

ISSN: 0920-3206

DAY: 11

MONTH: Aug

YEAR: 2007

Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusion. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8712220

Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusion. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusion. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusion.

AFFILIATION: Department of Pharmacology, Sikkim Manipal Institute of Medical Sciences, 5th Mile, Tadong, Gangtok, Sikkim, India. biswadeepdas@hotmail.com

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cardiovasc Drugs Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial KATP channel activation in the intact rabbit heart during ischemia/reperfusion Related Publications

• A 21-month-old child with acute spastic parapapresis.
• A Novel Phenalenone from Salvia moorcraftiana.
• A dynamics model for nonlinear electrostrictive actuators.
• Angioplasty of degenerated saphenous vein grafts--role of covered stents.
• Assessing medical student learning in assessing the quality of health information on the internet and communicating the skill to patients.
• Bubble sizing with high spatial resolution.
• CRP in acute appendicitis--is it a necessary investigation?
• Central nervous system cladosporiosis: An account of ten culture-proven cases.
• Cryptococcal choroid plexitis as a mass lesion: MR imaging and histopathologic correlation.
• Cryptococcal meningitis: Clinical, diagnostic and therapeutic overviews.
• Cytotoxicity of Pseudomonas secreted exotoxins requires OxyR expression.
• Dysmyelinating neuropathy in benign form of megalencephalic leukoencephalopathy with subcortical cysts: A novel observation from south India.
• Giant serpentine aneurysm of vertebrobasilar artery mimicking dolichoectasia--an unusual complication of pediatric AIDS. Report of a case with review of the literature.
• Homocysteine and cerebral stroke in developing countries.
• Interfering antiviral immunity: application, subversion, hope?
• Low recovery rates of high-level aminoglycoside-resistant enterococci could be attributable to restricted usage of aminoglycosides in Indian settings.
• Modeling resonance tests for electrostrictive ceramics.
• Nurses' Health Education Program in India Increases HIV Knowledge and Reduces Fear.
• Peripheral vascular disease in systemic lupus erythematosus.
• Perturbed bone marrow monocyte development following burn injury and sepsis promote hyporesponsive monocytes.
• Pharmacogenomics--a new approach towards personalized medicine.
• Pneumocystis pneumonia in children receiving chemotherapy.
• Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusion.
• Problem-based learning: the right direction for medical teaching?
• Quetiapine-induced leucopenia and thrombocytopenia.
• Ramelteon: A melatonin receptor agonist for the treatment of insomnia.
• Safety of cervical transforaminal steroid injections.
• Severity of burn injury and sepsis determines the cytokine responses of bone marrow progenitor-derived macrophages.
• Speckle reduction in ultrasound B-scans using weighted averaging in spatial compounding.
• Thoracoscopic thymectomy in a previous sternotomy.